UH HYUN KIM | Bio Chemistry | Best Paper Award

Published on by Best Paper Awards

Best Paper Award

UH HYUN KIM
Affiliation Wonkwang University
Country South Korea
Scopus ID 7102248950
ORCID 0000-0003-3304-7190
Documents 117
Citations 4,627
h-index 40
Subject Area Biochemistry
Event Best Paper Awards

UH HYUN KIM

UH HYUN KIM of Wonkwang University, South Korea is recognized with the Best Paper Award for research excellence in the field of Biochemistry [1]. The recognized research, titled “The Na+/K+-ATPase β1 Subunit is a Kidney ADP-Ribosyl Cyclase,” investigates the biochemical function of the Na+/K+-ATPase β1 subunit and its relationship with ADP-ribosyl cyclase activity in the kidney.

Abstract

This article recognizes UH HYUN KIM with the Best Paper Award for research excellence in Biochemistry [1]. The recognized research, titled “The Na+/K+-ATPase β1 Subunit is a Kidney ADP-Ribosyl Cyclase,” focuses on the functional characteristics of the Na+/K+-ATPase β1 subunit in kidney biology. The study highlights a biochemical relationship between this subunit and ADP-ribosyl cyclase activity, contributing to the broader understanding of membrane-associated proteins and biochemical signaling mechanisms.

Keywords

Best Paper Award, UH HYUN KIM, Biochemistry, Na+/K+-ATPase, β1 Subunit, Kidney, ADP-Ribosyl Cyclase, Kidney Biochemistry, Membrane Proteins, Enzyme Activity [1].

Introduction

The awarded research, “The Na+/K+-ATPase β1 Subunit is a Kidney ADP-Ribosyl Cyclase,” addresses an important biochemical question concerning the functional role of the Na+/K+-ATPase β1 subunit. The Na+/K+-ATPase system is associated with cellular ion regulation, while ADP-ribosyl cyclase activity is relevant to biochemical signaling processes. The research connects these concepts by examining the β1 subunit in the context of kidney-associated ADP-ribosyl cyclase activity [2].

Research Profile

UH HYUN KIM is affiliated with Wonkwang University, South Korea and is associated with the subject area of Biochemistry. According to the provided academic information, the researcher has 117 documents, 4,627 citations, and an h-index of 40. The Scopus author identifier supplied for the researcher is 7102248950 [3].

Research Contributions

The recognized publication contributes to Biochemistry by examining the functional identity of the Na+/K+-ATPase β1 subunit as a kidney ADP-ribosyl cyclase. By connecting a membrane-associated protein subunit with enzymatic activity, the research provides a basis for considering additional biochemical functions of the β1 subunit beyond its established structural association with Na+/K+-ATPase [2].

Research Impact

The provided academic profile records 117 documents, 4,627 citations, and an h-index of 40 for UH HYUN KIM [3]. These bibliometric indicators demonstrate an established scholarly publication record and substantial citation activity.

Award Suitability

The Best Paper Award recognizes outstanding research based on factors including originality, significance, research quality, and the contribution and impact of published work [1]. UH HYUN KIM’s recognized research aligns with these objectives through its investigation of the Na+/K+-ATPase β1 subunit and its association with kidney ADP-ribosyl cyclase activity.

Conclusion

UH HYUN KIM has an established research profile in Biochemistry, with the provided academic information recording 117 documents, 4,627 citations, and an h-index of 40 [3]. The recognized publication, “The Na+/K+-ATPase β1 Subunit is a Kidney ADP-Ribosyl Cyclase,” examines an important biochemical relationship involving the Na+/K+-ATPase β1 subunit and kidney ADP-ribosyl cyclase activity [2].

The combination of a focused biochemical research contribution and an established scholarly record supports the recognition of UH HYUN KIM in connection with the Best Paper Award [1].

External Links

References

  1. Best Paper Awards.
    International Research Excellence and Best Paper Awards. Best Paper Awards Website.
    https://bestpaperawards.com/
  2. UH HYUN KIM – Scopus Author Profile.
    Scopus Author ID: 7102248950.
    View Scopus Profile
  3. UH HYUN KIM – ORCID Profile.
    ORCID: 0000-0003-3304-7190.
    View ORCID Profile

Xiao-Jun Du | Biochemistry | Best Review Article Award

Published on by Best Paper Awards
Best Researcher Award
Xiao-Jun Du — Baker Heart and Diabetes Institute, Australia
Xiao-Jun Du
Affiliation Baker Heart and Diabetes Institute
Country Australia
Scopus ID 7402551956
Documents 241
Citations 12,313
h-index 62
Subject Area Biochemistry
Event Best Paper Awards

Xiao-Jun Du is a researcher associated with the Baker Heart and Diabetes Institute, Australia, whose work contributes to the field of Biochemistry with emphasis on metabolic regulation and cardiovascular disease mechanisms. This article summarizes his academic profile, research output, and scholarly impact using bibliometric indicators such as Scopus records, citation metrics, and h-index evaluation. With 241 documents and 12,313 citations, his research demonstrates consistent contributions to biomedical science. The profile also discusses recognition through awards including the Best Paper Awards event. Overall, the study highlights his influence in translational research and potential suitability for scientific recognition and academic leadership globally.

Abstract

Xiao-Jun Du is a researcher associated with the Baker Heart and Diabetes Institute, Australia, whose work contributes to the field of Biochemistry with emphasis on metabolic regulation and cardiovascular disease mechanisms. This article summarizes his academic profile, research output, and scholarly impact using bibliometric indicators such as Scopus records, citation metrics, and h-index evaluation. With 241 documents and 12,313 citations, his research demonstrates consistent contributions to biomedical science. The profile also discusses recognition through awards including the Best Paper Awards event. Overall, the study highlights his influence in translational research and potential suitability for scientific recognition and academic leadership globally.

Keywords

Biochemistry; Cardiovascular Disease; Metabolic Regulation; Bibliometrics; Scopus; h-index; Translational Research; Biomedical Science

Introduction

Xiao-Jun Du is an academic researcher affiliated with the Baker Heart and Diabetes Institute, Australia, working in Biochemistry and related biomedical sciences. His research focuses on molecular mechanisms underlying cardiometabolic diseases. This article presents an overview of his scholarly metrics, publications, and academic recognition within global scientific communities worldwide impact.

Research Profile

Xiao-Jun Du’s research profile reflects extensive contributions to cardiovascular and metabolic biochemistry. He has authored numerous peer-reviewed publications and collaborated internationally. His academic output is indexed in Scopus, demonstrating sustained research productivity. The profile highlights his expertise in disease mechanisms, biomarker discovery, and translational biomedical research applications and innovation focus.

Research Contributions

His research contributions include significant advancements in understanding cardiovascular disease pathways and metabolic regulation. He has contributed to experimental studies identifying molecular targets for therapy development. His interdisciplinary work bridges basic science and clinical research, strengthening translational outcomes and supporting innovation in biomedical diagnostics and treatment strategies global research impact.

Publications

His publication record comprises articles in peer-reviewed international journals focusing on biochemistry, cardiometabolic disease, and molecular biology. Indexed databases such as Scopus reflect his consistent scholarly output. These publications contribute to advancing scientific understanding and support ongoing research collaborations across global academic institutions and interdisciplinary biomedical knowledge and expansion globally.

Research Impact

His research impact is evidenced by citation metrics, academic recognition, and contributions to high-impact biomedical studies. With over 12,313 citations and an h-index of 62, his work demonstrates strong influence in the scientific community. His findings support advancements in cardiovascular and metabolic disease research worldwide and translational science relevance globally.

Award Suitability

His academic profile indicates strong suitability for recognition in international scientific awards. His contributions to biochemistry and cardiovascular research demonstrate consistent excellence and innovation. The combination of high citation impact, extensive publications, and interdisciplinary collaboration positions him as a candidate for distinguished research honors and professional acknowledgment global academic recognition.

Conclusion

This overview highlights Xiao-Jun Du’s contributions to biochemistry and biomedical research, emphasizing his academic productivity and citation impact. His work continues to support advancements in cardiovascular and metabolic disease understanding. Ongoing research engagement ensures sustained relevance in global scientific discourse and future biomedical innovation and continued academic research excellence globally.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Xiao-Jun Du, Author ID 7402551956. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7402551956
  2. Best Paper Awards. (n.d.). Official event information and recognition listing.
    https://bestpaperawards.com/

  3. Galectin-3 gene deletion alters lipid profile in healthy and cardiomyopathy mouse hearts.
    https://www.researchgate.net/publication/394312305_Galectin-3_gene_deletion_alters_lipid_profile_in_healthy_and_cardiomyopathy_mouse_hearts

P. V. G. K Sarma | Biochemistry | Editorial Board Member

Published on by Best Paper Awards

Assoc. Prof. Dr. P. V. G. K Sarma | Biochemistry | Editorial Board Member 

Associate Professor | Sri Venkateswara Institute of Medical Sciences | India

P. V. G. K. Sarma is a senior Indian biotechnologist and academic leader currently serving as the Head of the Department of Biotechnology at the Sri Venkateswara Institute of Medical Sciences, Tirupati, a position he has held since 2004, with his academic training from JNTU Hyderabad and a broad research portfolio reflected in over a hundred scholarly publications indexed across major journals. P. V. G. K. Sarma His core research spans genetic engineering, microbial biotechnology, functional genomics, structural bioinformatics, and stem cell differentiation with a strong translational focus on regenerative medicine and human disease. A major strength of his work lies in the in vitro differentiation of human CD34+ hematopoietic stem cells into diverse lineages including pancreatic β-cells, erythrocytes, podocytes, type-II pneumocytes, keratinocytes, chondrocytes, and megakaryocytes, contributing to the understanding of cellular plasticity and therapeutic cell generation. Parallel to this, he has made significant contributions to microbial pathogenesis, particularly on Staphylococcus aureus, elucidating molecular mechanisms of biofilm formation, metabolic regulation, and antimicrobial resistance, including MRSA, through gene expression, enzyme activity, and structure-based drug design approaches. His interdisciplinary research also addresses clinical and molecular genetics, with notable studies on mutations linked to congenital erythrocytosis, breast cancer, leukemia drug resistance, rheumatoid arthritis, tuberculosis susceptibility, cardiovascular disease, and pain genetics. During the COVID-19 period, his in silico investigations on antiviral compounds targeting SARS-CoV-2 proteins further demonstrated his adaptability across emerging biomedical challenges. He has consistently integrated wet-lab experimentation with computational biology, signaling pathways, and nanobiotechnology, including cytotoxicity studies of silver nanoparticles on human stem cells. Beyond research, he is actively involved in peer review for reputed international journals and contributes to clinical translational science through collaborations across medicine, genetics, and biotechnology. Collectively, his career reflects sustained leadership in Indian biomedical research, with impactful contributions to stem cell biology, microbial biotechnology, and molecular genetics aimed at advancing diagnostics, therapeutics, and regenerative strategies.

Profile: ORCID

Featured Publications

  1. Chandrasekhar, C., Kumar, P. S., & Sarma, P. V. G. K. (2019). Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Scientific Reports, 9, 38672.

  2. Loganathan, S. E., Kattaru, S., Kodavala, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). Prominent expression of COL2A1, ACAN and IHH genes observed in the differentiation of human hematopoietic stem cells into articular type of chondrocytes. Stem Cell Reviews and Reports, 20.

  3. Kodavala, S., Loganathan, S. E., Kattaru, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). In vitro generation of epidermal keratinocytes from human CD34-positive hematopoietic stem cells. In Vitro Cellular & Developmental Biology – Animal, 60.

  4. Suthi, S., Mounika, A., & Sarma, P. V. G. K. (2023). Elevated acetate kinase (ackA) gene expression, activity, and biofilm formation observed in methicillin-resistant strains of Staphylococcus aureus. Journal of Genetic Engineering and Biotechnology, 21.

  5. Kattaru, S., Manne Mudhu, S., Loganathan, S. E., Kodavala, S., & Sarma, P. V. G. K. (2021). Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of Langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract. Molecular Biology Reports, 48.

P. V. G. K. Sarma has advanced translational biotechnology through pioneering stem cell differentiation, molecular genetics, and microbial pathogenesis research that directly supports regenerative medicine and precision diagnostics. His work bridges laboratory science with clinical and industrial applications, contributing to improved disease understanding, therapeutic development, and global biomedical innovation.